Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 6515 (MIR6515) is a human microRNA gene encoding a short (~20–24 nucleotide) non-coding RNA molecule that modulates gene expression post-transcriptionally. Mature MIR6515 is incorporated into the RNA-induced silencing complex (RISC), binding target mRNAs to inhibit their translation or promote destabilization. MIR6515-5p has been implicated in the regulation of inflammatory responses in human bronchial epithelial cells—specifically, it targets CSF3, a cytokine involved in immune signaling, in the context of particulate matter exposure. MIR6515 is one of many human microRNAs with context- and tissue-dependent function. Its expression may serve as a biomarker for certain disease states, such as being upregulated in asymptomatic Moyamoya disease, a rare cerebrovascular disorder.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 6515 (MIR6515).